Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.
Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.
Although a majority of women with rheumatoid arthritis were previously though to achieve remission during pregnancy, recent studies indicate remission occurs in only 20% to 40% of cases.
In patients with rheumatoid arthritis, vitamin D deficiency was shown to be associated with increased neuropathic pain.
Tocilizumab was associated with significant improvements in hemoglobin and hematocrit over 2 years of treatment in patients with rheumatoid arthritis.
For patients with chronic fatigue syndrome/fibromyalgia or rheumatoid arthritis, morphine has anti-hyperalgesic effects comparable with placebo.
Increased baseline gene expression in peripheral blood may be associated with improved clinical response to methotrexate in rheumatoid arthritis.
A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.
Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.
Peripheral anti-IL-6 cytokine treatment is associated with improvement in depressive symptoms in patients with RA.
MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.
Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.
A high prevalence and risk for metabolic syndrome was found in patients with rheumatoid arthritis.
The FDA has approved Renflexis, the second approved biosimilar to Remicade.
Patients with RA suffering from S. aureus infection have more complications and higher mortality rates than patients without RA.
EULAR recommendations were updated for rheumatoid arthritis management to include new guidelines on starting effective therapy in patients early.
No evidence was found of a higher cardiovascular risk among rheumatoid arthritis patients who switched from a different biologic drug or tofacitinib to tocilizumab vs to a tumor necrosis factor inhibitor.
Urinary proteomics may help identify biomarkers that can distinguish between different types of inflammatory arthritis.
Early identification and treatment of patients with RA is central to successfully limiting joint damage and disease progression.
Telerheumatology can improve healthcare access, patient outcomes, and costs
No statistically significant association was found between MTX or anti-TNF use and breast cancer recurrence.
Knee OA was associated with cortical thinning in brain regions not typically associated with pain processing.
MBDA scores combined with ACPA testing allowed researchers to predict RA relapse in more than 80% of patients.
"Based on our 2 study populations, individuals with chronic pain experienced more severe depressive, anxiety, and stress symptoms compared to those with chronic RA."
Age and cigarette smoking are associated with inflammatory joint signs in a high-risk cohort of RA first-degree relatives.
The Short-Form Health Survey as an Effective Diagnostic Tool for Psychiatric Comorbidities in RA PatientsAugust 02, 2016
The analysis found that the SF-36 survey was an effective diagnostic tool for MDD and GAD in patients with RA.
Assessing epidemiologic and genetic factors among individuals with positive family history of RA may identify those suitable for RA prevention strategies
The heterogeneity of RA pathologic processes renders development of adapted treatments challenging, calling for a better understanding of location-specific disease mechanisms.
Better efficacy for tocilizumab versus abatacept and rituximab in patients with first non-TNFi failure.
The use of a postoperative risk stratification model can serve to reduce the costs associated with hospital readmission by identifying patients with specific risk factors.
Clinical Pain Advisor Articles
- Virtual Reality for Pain Relief: Understanding the Underlying Mechanisms
- Vibrating Gloves Significantly Reduce Osteoarthritis-Related Hand Pain
- Neuroimaging for Chronic Pain: IASP Consensus Statement
- Neuroinflammation in Neuropathic Pain Indicated by Elevated Levels of Proinflammatory Chemokines in CSF
- Hypertension in Chronic Pain: Risk Factors
- Liposomal Bupivacaine Effective for Shoulder Arthroplasty-Related Pain
- Reducing the P-Value for Statistical Significance to Improve the Quality of Research?
- FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids
- Electrotherapy, Acupuncture May Decrease Pain Following Total Knee Arthroplasty
- Low-Dose Oromucosal Ibuprofen Effective for Relieving Sore Throat
- Survey Finds Teens Divided on Beliefs and Attitudes of Prescription Drug Abuse
- HIV-Positive Patients Experience Frequent Headaches
- Low-Dose Perineural Dexamethasone Prolongs Effects of Brachial Plexus Nerve Block
- Business Savvy Tips for Buying a Practice
- Diphenhydramine Decreases Pain During Colonoscopy for Chronic Opioid Users